Internal Medicine, Hematology & Oncology · Weston, FL
NPI
1487824124
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2950 Cleveland Clinic Blvd
Weston, FL, 33331
Phone (954) 659-5840
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
975 services
Medicare patients, 2024
235
Average age 75
Drug cost, 2024
$10.2M
1,217 prescriptions
Company payments, 2025
$44K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chakra P Chaulagain was code 99215 (office e&m - established), 299 times for 103 patients. In total Chakra P Chaulagain billed 975 services in 14 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 299 | 103 | $114.28 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 165 | 124 | $13.47 | $2,222 |
| 99214 Office E&M - Established | Facility | 138 | 103 | $71.31 | $9,841 |
| 99233 Hospital E&M - Subsequent | Facility | 59 | 21 | $97.74 | $5,767 |
| 99205 Office E&M - New | Facility | 21 | 21 | $143.69 | $3,018 |
| 99223 Hospital E&M - Initial | Facility | 17 | 12 | $143.21 | $2,435 |
| 99215 Office E&M - Established | Office | 15 | 15 | $52.25 | $784 |
| 99214 Office E&M - Established | Office | 15 | 13 | $72.58 | $1,089 |
| 99204 Office E&M - New | Facility | 13 | 13 | $111.14 | $1,445 |
By year: 2022 $2.2M for 73,630 services; 2023 $1.4M for 45,818 services; 2024 $70K for 975 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chakra P Chaulagain prescribed most often to Medicare patients was Revlimid (Lenalidomide), with 214 prescriptions and refills. In total Chakra P Chaulagain wrote 1,217 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Revlimid Lenalidomide | 214 | 214 | 34 | $4.1M |
| Lenalidomide Generic | 71 | 71 | 14 | $1.0M |
| Valacyclovir Valacyclovir Hcl | 60 | 171 | 24 | $3,768 |
| Brukinsa Zanubrutinib | 60 | 60 | Under 11 | $625K |
| Hydroxyurea Generic | 57 | 152 | 17 | $1,573 |
| Acyclovir Generic | 53 | 97 | 16 | $545 |
| Jakafi Ruxolitinib Phosphate | 49 | 49 | Under 11 | $755K |
| Venclexta Venetoclax | 39 | 39 | Under 11 | $422K |
| Pomalyst Pomalidomide | 37 | 37 | Under 11 | $878K |
| Clonazepam Generic | 35 | 39 | Under 11 | $417 |
| Oxycodone Hcl Generic | 30 | 30 | Under 11 | $1,230 |
| Prednisone Generic | 23 | 26 | 20 | $57.89 |
| Cerdelga Eliglustat Tartrate | 22 | 22 | Under 11 | $702K |
| Tenofovir Disoproxil Fumarate Generic | 22 | 36 | Under 11 | $1,457 |
| Allopurinol Generic | 20 | 44 | 14 | $103 |
Brand drugs: 562 claims; generic drugs: 655 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chakra P Chaulagain $44K ($44K in general payments such as food, travel and fees) from 25 companies. The largest payer was Janssen Biotech, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 36 | $18K |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $15K |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $4,476 |
| Geron Corporation GERN | 6 | $3,381 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $2,200 |
| GlaxoSmithKline, LLC. GSK | 12 | $285 |
| Genzyme Corporation SNY | 5 | $122 |
| Pfizer Inc. PFE | 6 | $118 |
| Daiichi Sankyo Inc. 4568.T | 3 | $85.35 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $76.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.